Literature DB >> 26216893

The Inflammatory Caspases-1 and -11 Mediate the Pathogenesis of Dermatitis in Sharpin-Deficient Mice.

Todd Douglas1, Claudia Champagne2, Alexandre Morizot2, Jean-Martin Lapointe3, Maya Saleh4.   

Abstract

Chronic proliferative dermatitis in mice (cpdm) is a spontaneous multiorgan inflammatory disorder with pathological hallmarks similar to atopic dermatitis and psoriasis in humans. Cpdm mice lack expression of SHANK-associated RH domain-interacting protein, an adaptor of the linear ubiquitin assembly complex, which acts in the NF-κB pathway to promote inflammation and protect from apoptosis and necroptosis. Although skin inflammation in cpdm mice is driven by TNF- and RIPK1-induced cell death, the contribution of initiating innate immunity sensors and additional inflammatory pathways remains poorly characterized. In this article, we show that inflammasome signaling, including the expression and activation of the inflammatory caspase-1 and -11 and IL-1 family cytokines, was highly upregulated in the skin of cpdm mice prior to overt disease onset. Genetic ablation of caspase-1 and -11 from cpdm mice significantly reduced skin inflammation and delayed disease onset, whereas systemic immunological disease persisted. Loss of Nlrp3 also attenuated skin disease, albeit more variably. Strikingly, induction of apoptosis and necroptosis effectors was sharply decreased in the absence of caspase-1 and -11. These results position the inflammasome as an important initiating signal in skin disease pathogenesis and provide novel insights about inflammasome and cell death effector cross-talk in the context of inflammatory diseases.
Copyright © 2015 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26216893     DOI: 10.4049/jimmunol.1500542

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  28 in total

1.  Genome-Wide Association Study of Cell-Mediated Response in Dogs Naturally Infected by Leishmania infantum.

Authors:  Luís F S Batista; Yuri T Utsunomiya; Thaís B F Silva; Raíssa A Dias; Thaise Y Tomokane; Acácio D Pacheco; Vânia L R da Matta; Fernando T Silveira; Mary Marcondes; Cáris M Nunes; Márcia D Laurenti
Journal:  Infect Immun       Date:  2016-11-18       Impact factor: 3.441

Review 2.  Inflammasomes in the pathophysiology of autoinflammatory syndromes.

Authors:  Sarang Tartey; Thirumala-Devi Kanneganti
Journal:  J Leukoc Biol       Date:  2019-10-14       Impact factor: 4.962

3.  Cross-regulation between LUBAC and caspase-1 modulates cell death and inflammation.

Authors:  Todd Douglas; Maya Saleh
Journal:  J Biol Chem       Date:  2020-03-02       Impact factor: 5.157

4.  TNF/TNFR axis promotes pyrin inflammasome activation and distinctly modulates pyrin inflammasomopathy.

Authors:  Deepika Sharma; Ankit Malik; Clifford Guy; Peter Vogel; Thirumala-Devi Kanneganti
Journal:  J Clin Invest       Date:  2018-11-19       Impact factor: 14.808

Review 5.  The intersection of cell death and inflammasome activation.

Authors:  James E Vince; John Silke
Journal:  Cell Mol Life Sci       Date:  2016-04-11       Impact factor: 9.261

Review 6.  Autoinflammatory Skin Disorders: The Inflammasomme in Focus.

Authors:  Prajwal Gurung; Thirumala-Devi Kanneganti
Journal:  Trends Mol Med       Date:  2016-06-03       Impact factor: 11.951

Review 7.  Function and regulation of IL-1α in inflammatory diseases and cancer.

Authors:  Ankit Malik; Thirumala-Devi Kanneganti
Journal:  Immunol Rev       Date:  2018-01       Impact factor: 12.988

Review 8.  SHARPIN: Role in Finding NEMO and in Amyloid-Beta Clearance and Degradation (ABCD) Pathway in Alzheimer's Disease?

Authors:  Dhanya Krishnan; Ramsekhar N Menon; Srinivas Gopala
Journal:  Cell Mol Neurobiol       Date:  2021-01-05       Impact factor: 5.046

Review 9.  Targeting RIP Kinases in Chronic Inflammatory Disease.

Authors:  Mary Speir; Tirta M Djajawi; Stephanie A Conos; Hazel Tye; Kate E Lawlor
Journal:  Biomolecules       Date:  2021-04-28

Review 10.  The 'cytokine storm': molecular mechanisms and therapeutic prospects.

Authors:  Rajendra Karki; Thirumala-Devi Kanneganti
Journal:  Trends Immunol       Date:  2021-07-01       Impact factor: 19.709

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.